Skip to main content
☰
moat
keep
Markets
News
Screener
Research
Editorials
Pricing
About
⌘K
Sign in
Start free
ABVC BIOPHARMA, INC. (ABVC) stock — financials, valuation and filings | Moatkeep
Companies
/
Nasdaq
/
ABVC
ABVC BIOPHARMA, INC.
ABVC · Nasdaq
$0.96
−2.87%
Close, 2026-11-12
Close, 2026-11-12 · source: Databento · USD · figures not investment advice
+ Alert
★ Watchlist
Overview
News
Valuation
Financials
Reports
Editorials & Research
Business
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
MAX
⤢ Expand
Price
▾
Log
Volume
Events
▾
Window
-97.3%
vs low
+130.0%
vs high
-97.5%
Price
through 2026-11-12
ex-date (0) · fiscal quarter (0)
Dividends: company filings (SEC EDGAR) and the historical exchange record.
State of incorporation
NV
Fiscal year end
Dec 31
Financials · latest year
USD millions
FY2025
Revenue
0
Net Income
-8
FY2024
•••••
•••••
FY2023
•••••
•••••
FY2022
•••••
•••••
FY2021
•••••
•••••
Read the full financial statements
Create a free account to see 5 years of financial history
Create a free account
Source: SEC EDGAR (XBRL) · figures in USD millions
View full financials →
Related companies
NAII
—
NATURAL ALTERNATIVES INTERNATIONAL INC
CNSY
—
CERENOME, INC.
MGX
—
Metagenomi Therapeutics, Inc.
NXTC
—
NextCure, Inc.
APWC
—
ASIA PACIFIC WIRE & CABLE CORP LTD
BRLS
—
Borealis Foods Inc.
MLSS
—
MILESTONE SCIENTIFIC INC.
FKWL
—
FRANKLIN WIRELESS CORP